22nd May 2017 07:00
RNS Number : 7012F
Immupharma PLC
22 May 2017
22 MAY 2017
ImmuPharma PLC
("ImmuPharma" or the "Company")
NOTIFICATION OF FULL YEAR RESULTS
Date: 1 June 2017
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 December 2016 on Thursday 1 June 2017.
-Ends-
For further information please contact: ImmuPharma plc (www.immupharma.org) | + 44 (0) 20 7152 4080 | Tim McCarthy, Chairman |
| Lisa Baderoon, Head of Investor Relations Twitter: @immupharma | + 44 (0) 7721 413496 |
|
| Northland Capital Partners Limited (Joint Broker) Patrick Claridge, David Hignell, Corporate Finance Rob Rees, Corporate Broking | +44 (0)20 3861 6625 |
|
|
|
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORKMGMKZLVGNZM
Related Shares:
Immupharma
